Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma

Neoadjuvant and Adjuvant Therapy for Renal Cell Carcinoma

Patients undergoing definitive surgery or ablative techniques for nonmetastatic kidney cancer have varying degrees of risk of recurrent disease post procedure. The ultimate goal of “adjuvant therapy” is to reduce the incidence of recurrent disease, and to cure more patients. We summarize the current...

Ամբողջական նկարագրություն

Մատենագիտական մանրամասներ
Հիմնական հեղինակներ:	Naomi B. Haas, Jeffrey Shevach, Ian D. Davis, Tim Eisen, Marine Gross-Gupil, Anil Kapoor, Viraj A. Master, Christopher W. Ryan, Manuela Schimdinger
Ձևաչափ:	Հոդված
Լեզու:	English
Հրապարակվել է:	The Société Internationale d’Urologie (SIU) 2022-11-01
Շարք:	Société Internationale d’Urologie Journal
Խորագրեր:	adjuvant therapy neoadjuvant therapy vascular endothelial growth factor receptor tyrosine kinase inhibitor immune checkpoint inhibitor renal celll carcinoma
Առցանց հասանելիություն:	https://siuj.org/index.php/siuj/article/download/222/164

Նմանատիպ նյութեր

Dancing with the Surgeon: Neoadjuvant and Adjuvant Immunotherapies from the Medical Oncologist’s Perspective
‌: Sehhoon Park
Հրապարակվել է: (2023-03-01)

Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma
‌: Takaya Komori, և այլն
Հրապարակվել է: (2025-01-01)

Neoadjuvant systemic therapy for hepatocellular carcinoma
‌: R. Connor Chick, և այլն
Հրապարակվել է: (2024-03-01)

Small molecule inhibitors as adjuvants in cancer immunotherapy: enhancing efficacy and overcoming resistance
‌: Xiaolin Wu, և այլն
Հրապարակվել է: (2024-08-01)

Systemic Drugs for Hepatocellular Carcinoma: What Do Recent Clinical Trials Reveal About Sequencing and the Emerging Complexities of Clinical Decisions?
‌: Himmelsbach V, և այլն
Հրապարակվել է: (2024-02-01)

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC
‌: Zhenyun Yang, և այլն
Հրապարակվել է: (2024-12-01)

Perioperative immunotherapy in stage IB-III non-small cell lung cancer: a critical review of its rationale and considerations
‌: Jae Kyeom Sim, և այլն
Հրապարակվել է: (2023-11-01)

Neoadjuvant personalized cancer vaccines: the final frontier?
‌: Guilhem Richard, և այլն
Հրապարակվել է: (2024-12-01)

Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab
‌: Margaux Dubus, MD, և այլն
Հրապարակվել է: (2023-08-01)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
‌: John ML Ebos, և այլն
Հրապարակվել է: (2014-10-01)

Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report
‌: Claire V. Ong, և այլն
Հրապարակվել է: (2024-03-01)

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma
‌: Virginia Ferraresi, և այլն
Հրապարակվել է: (2022-05-01)

Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis
‌: Yanxiong Mao, և այլն
Հրապարակվել է: (2024-11-01)

Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer
‌: Laura Valerio, և այլն
Հրապարակվել է: (2025-02-01)

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
‌: Guy Jerusalem, և այլն
Հրապարակվել է: (2023-12-01)

A real-world retrospective study to assess efficacy and safety of alectinib as adjuvant therapy in IB-IIIB NSCLC patients harboring ALK rearrangement
‌: Zeng-Hao Chang, և այլն
Հրապարակվել է: (2024-10-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
‌: Freshte Foroughi, և այլն
Հրապարակվել է: (2024-12-01)

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer
‌: Madeleine B. Hopson, և այլն
Հրապարակվել է: (2024-03-01)

Exploring potential predictive biomarkers through historical perspectives on the evolution of systemic therapies into the emergence of neoadjuvant therapy for the treatment of hepatocellular carcinoma
‌: Chuanlei Wang, և այլն
Հրապարակվել է: (2024-06-01)

Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review
‌: Lingbo Hu, և այլն
Հրապարակվել է: (2024-05-01)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
‌: Jia‐Bin Wang, և այլն
Հրապարակվել է: (2023-05-01)

Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics
‌: Marco Chiappetta, և այլն
Հրապարակվել է: (2022-11-01)

Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
‌: Lavinia Gatteschi, և այլն
Հրապարակվել է: (2021-10-01)

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use
‌: Won Jin Jeon, և այլն
Հրապարակվել է: (2023-06-01)

Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study
‌: Junfeng Bu, և այլն
Հրապարակվել է: (2025-02-01)

Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
‌: Jiale Gao, և այլն
Հրապարակվել է: (2023-02-01)

Cure can be achieved by conversion to microwave ablation following atezolizumab-bevacizumab therapy in unresectable hepatocellular carcinoma
‌: Rene John D. Febro, և այլն
Հրապարակվել է: (2024-09-01)

Additive toxicity arising from combined use of immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with renal or endometrial carcinoma: Protocol for a rapid systematic review
‌: Shannon E. Kelly, և այլն
Հրապարակվել է: (2024-06-01)

Clinical significance of combination of anti-angiogenesis, immune checkpoint inhibitors and chemotherapy in the neoadjuvant treatment of locally advanced gastric cancer
‌: ZHU Zhenggang
Հրապարակվել է: (2024-03-01)

Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario
‌: Valeria Fuorivia, և այլն
Հրապարակվել է: (2024-08-01)

Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer
‌: Yan Wang, և այլն
Հրապարակվել է: (2024-12-01)

Adjuvant and Neoadjuvant Therapy for Breast Cancer: A Systematic Review
‌: Amal Sayfuldeen Qari, և այլն
Հրապարակվել է: (2024-07-01)

Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer
‌: Saachi Chhaya, և այլն
Հրապարակվել է: (2023-01-01)

Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study
‌: Cai H, և այլն
Հրապարակվել է: (2024-02-01)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
‌: Shigenori Ei, և այլն
Հրապարակվել է: (2023-09-01)

Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study
‌: Wen‐Jin Zhong, և այլն
Հրապարակվել է: (2024-02-01)

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
‌: Nargiz Majidova, և այլն
Հրապարակվել է: (2025-01-01)

Mono‐TKI and TKI Plus ICI in Unresectable Hepatocellular Carcinoma Progression on First‐Line Treatment of Lenvatinib: A Real‐World Study
‌: Xue Yin, և այլն
Հրապարակվել է: (2025-03-01)

Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review
‌: Xin-Liang Liu, և այլն
Հրապարակվել է: (2024-03-01)

Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
‌: Gian Marco Leone, և այլն
Հրապարակվել է: (2023-04-01)